Orchestra BioMed Holdings (OBIO) Consolidated Net Income (2022 - 2025)
Historic Consolidated Net Income for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to -$20.8 million.
- Orchestra BioMed Holdings' Consolidated Net Income fell 3501.88% to -$20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.1 million, marking a year-over-year decrease of 3371.97%. This contributed to the annual value of -$60.9 million for FY2024, which is 2788.26% down from last year.
- Latest data reveals that Orchestra BioMed Holdings reported Consolidated Net Income of -$20.8 million as of Q3 2025, which was down 3501.88% from -$19.4 million recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Consolidated Net Income registered a high of -$5.1 million during Q1 2022, and its lowest value of -$20.8 million during Q3 2025.
- Over the past 4 years, Orchestra BioMed Holdings' median Consolidated Net Income value was -$13.4 million (recorded in 2024), while the average stood at -$13.5 million.
- In the last 5 years, Orchestra BioMed Holdings' Consolidated Net Income crashed by 12513.65% in 2023 and then tumbled by 1335.15% in 2024.
- Orchestra BioMed Holdings' Consolidated Net Income (Quarter) stood at -$9.8 million in 2022, then decreased by 15.72% to -$11.4 million in 2023, then plummeted by 42.05% to -$16.2 million in 2024, then decreased by 28.93% to -$20.8 million in 2025.
- Its last three reported values are -$20.8 million in Q3 2025, -$19.4 million for Q2 2025, and -$18.8 million during Q1 2025.